Author: Lynne Taylor

43% of men and 50% of women in England have told a government survey that they had taken at least one prescribed medicine in the last week, and 22% of men and 24% of women reported that they had taken at least three prescribed drugs during the period.

Proposed new arrangements for prioritising access to the Cancer Drug Fund “will continue to undermine NICE, duplicate effort and distort allocation of NHS resources, while failing to support the development of cost-effective drugs from which patients will benefit,” says a team of leading health economists.

Novel emerging treatments are set to reinvigorate the market for dyslipidemia therapies, which is currently constrained by patent expirations on leading products, according to new research.

Healthcare outcomes in the UK remain among the best in the world, but the nation spends slightly more than its peers to achieve them, according to The Economist Intelligence Unit’s Health Outcomes and Spending Index.

Sales of migraine drug treatments in six major markets are set to grow an average of 5.8% a year, rising from around $3 billion in 2013 to over £5 billion in 2023, say new forecasts.